510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1415-2017Class II

Merge Cardio software using EchoIMS. The firm name on the label is Merge Healthcare, Hartland, WI

Merge Healthcare Incorporated / initiated 2016-04-04 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge Cardio software using EchoIMS. The firm name on the label is Merge Healthcare, Hartland, WI on . FDA classified it as Class II and gives the reason as "A situation can occur allowing two physicians to access the same study report in EchoIMS when launched from the Cardio Study List without receiving the read-only notification prompt". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1415-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge Cardio software using EchoIMS. The firm name on the label is Merge Healthcare, Hartland, WI.
Product code
LLZ System, Image Processing, Radiological
Reason for recall
A situation can occur allowing two physicians to access the same study report in EchoIMS when launched from the Cardio Study List without receiving the read-only notification prompt.
Root cause tag
software
FDA root cause
Software design
Action
Merge sent an Urgent: Medical Device Recall letter dated March 28, 2016, via e-mail on April 4, 2016. A letter was issued to nonresponders on July 11, 2016. The letter notifies the customer of the issue, informs them of the workaround, and that no further action was being taken to correct the issue, therefore, the customer needs to be aware of the possible behavior. The notification instructs the customer to pass the information onto all other users, as well as any downstream customers if it was further distributed. The notification also informs the customer their response is required using the enclosed form and the return addressed envelope. The response form asks, in part, if they understand the workaround. The response was required no later than April 18, 2016. Nonresponders were issued a second letter dated July 11, 2016, asking for a response by August 2, 2016. The letter and response form contained the same information as the first letter. If the second letter results in additional unresponsive customers, a call campaign will be managed by Customer Support and documented via SalesForce. Three call attempts will made before closing the case. For further information please call (877) 741-5369.
Quantity in commerce
17 sites potentially have the affected versions
Distribution
US Distribution was made to medical facilities in CA, FL, IL, MD, MO, OH, OK, TX, VT, and WI. Military distribution was also made.
Product codes and lots
Version 9.0.9 and earlier using EchoIMS.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1415-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1415-2017Class IITerminatedVoluntary: Firm initiated